Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kaye

Showing results (721-730 of 853) with videos related to

Pageof 86
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agentsG Schwartsmann, J Wanders, I J Koier, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2018
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trialsTerri Patricia McVeigh, Raghav Sundar, Nikolaos Diamantis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapyLiz Y Han, Vasilios Karavasilis, Tom van Hagen, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?Marta Capelan, Desamparados Roda, Elena Geuna, et al.
Biomedical Optics Express|January 4, 2018
Deformation velocity imaging using optical coherence tomography and its applications to the corneaSamuel Lawman, Peter W Madden, Vito Romano, et al.
Cornea|October 25, 2024
Preoperative Posterior Stromal Ripples as Predictive Biomarkers of Visual Recovery After DMEKMariacarmela Ventura, Matteo Airaldi, Chiara Ancona, et al.
Ophthalmic Genetics|September 27, 2023
Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndromeKeri Mc Lean, Stefano Bignotti, Michele Callea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Intergroup collaboration in ovarian cancer: a giant step forwardM J Piccart, G C Stuart, J Cassidy, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2010
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC seriesRoshan Agarwal, Charlie Gourley, Timothy J Perren, et al.
Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.
Pageof 86

Showing results (721-730 of 853) with videos related to

Sort By:
Pageof 86
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agentsG Schwartsmann, J Wanders, I J Koier, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2018
The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trialsTerri Patricia McVeigh, Raghav Sundar, Nikolaos Diamantis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapyLiz Y Han, Vasilios Karavasilis, Tom van Hagen, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?Marta Capelan, Desamparados Roda, Elena Geuna, et al.
Biomedical Optics Express|January 4, 2018
Deformation velocity imaging using optical coherence tomography and its applications to the corneaSamuel Lawman, Peter W Madden, Vito Romano, et al.
Cornea|October 25, 2024
Preoperative Posterior Stromal Ripples as Predictive Biomarkers of Visual Recovery After DMEKMariacarmela Ventura, Matteo Airaldi, Chiara Ancona, et al.
Ophthalmic Genetics|September 27, 2023
Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndromeKeri Mc Lean, Stefano Bignotti, Michele Callea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Intergroup collaboration in ovarian cancer: a giant step forwardM J Piccart, G C Stuart, J Cassidy, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2010
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC seriesRoshan Agarwal, Charlie Gourley, Timothy J Perren, et al.
Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.
Pageof 86